Publications by authors named "Jessica J O Steenbruggen"
The Safety, Tolerability, and Preliminary Efficacy of a Gemcitabine-releasing Intravesical System (TAR-200) in American Urological Association-defined Intermediate-risk Non-muscle-invasive Bladder Cancer Patients: A Phase 1b Study.
F Johannes P van Valenberg Antoine G van der Heijden Christopher J Cutie Sumeet Bhanvadia Kirk A Keegan Jessica J O Steenbruggen
Eur Urol Open Sci
April 2024
Background And Objective: Patients with intermediate-risk non-muscle-invasive bladder cancer (IR NMIBC) have a high risk of recurrence and need effective therapies to reduce the risk of disease recurrence or progression. This phase 1b study (NCT02720367) assessed the safety and tolerability of TAR-200, an intravesical drug delivery system, in participants with IR NMIBC.
Methods: Participants with recurrent IR NMIBC were eligible.